Raymond James & Associates Raises Holdings in Smith & Nephew plc (NYSE:SNN)

Raymond James & Associates lifted its holdings in Smith & Nephew plc (NYSE:SNN - Free Report) by 172.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 128,854 shares of the medical equipment provider's stock after purchasing an additional 81,500 shares during the quarter. Raymond James & Associates' holdings in Smith & Nephew were worth $4,013,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Blue Trust Inc. grew its holdings in shares of Smith & Nephew by 460.5% in the third quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider's stock worth $145,000 after acquiring an additional 3,827 shares during the period. Creative Planning grew its holdings in shares of Smith & Nephew by 28.6% in the third quarter. Creative Planning now owns 62,319 shares of the medical equipment provider's stock worth $1,941,000 after acquiring an additional 13,845 shares during the period. GAMMA Investing LLC grew its holdings in shares of Smith & Nephew by 160.0% in the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider's stock worth $70,000 after acquiring an additional 1,389 shares during the period. Sanctuary Advisors LLC bought a new stake in shares of Smith & Nephew in the second quarter worth $627,000. Finally, Brandes Investment Partners LP grew its holdings in shares of Smith & Nephew by 20.5% in the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider's stock worth $34,002,000 after acquiring an additional 233,293 shares during the period. Hedge funds and other institutional investors own 25.64% of the company's stock.

Smith & Nephew Price Performance

Shares of Smith & Nephew stock traded up $0.15 on Friday, hitting $25.24. The company's stock had a trading volume of 1,070,064 shares, compared to its average volume of 799,524. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. Smith & Nephew plc has a 1 year low of $23.24 and a 1 year high of $31.72. The firm has a fifty day moving average price of $29.98 and a 200-day moving average price of $27.84.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on SNN shares. Deutsche Bank Aktiengesellschaft downgraded Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Friday. StockNews.com upgraded Smith & Nephew from a "buy" rating to a "strong-buy" rating in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy".

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.